Resmetiron Market Outlook Signals Rising Demand for Advanced Metabolic Disease Treatments
The resmetiron market was valued at USD 258.5782 million in 2025 and is projected to grow from USD 291.627 million in 2026 to USD 844.5755 million by 2036, registering a CAGR of 11.2195% during the forecast period, according to Future Market Insights. The market is gaining momentum following regulatory approvals for resmetirom-based therapies targeting metabolic dysfunction-associated...
0 Comments 0 Shares 170 Views 0 Reviews